Advanced Therapeutics: R&D to Market - BSCI5002

Looking for a different module?

Module delivery information

Location Term Level1 Credits (ECTS)2 Current Convenor3 2026 to 2027
Canterbury
Spring Term 5 20 (10) checkmark-circle

Overview

How are advanced therapies developed, manufactured, and brought to patients? What challenges arise when turning cutting-edge science into real-world treatments? This module introduces the principles and applications of advanced therapies and ATMPs (Advanced Therapy Medicinal Products), including gene therapy, cell therapy, and tissue engineering. You will explore how these therapies are developed, delivered, and scaled for clinical use alongside key considerations in manufacturing, regulation, and commercialisation. You will also examine delivery methods, production processes, GMP and GCP basics, and the regulatory frameworks that govern advanced therapeutics—while assessing common challenges such as cost, scalability, and reasons for failure.

Details

Contact hours

Distant and Online blended learning: lectures, audio, recordings, video clips, study guides - 44 hours
'Live' contact hours: live teaching via webinars and induction - 10 hours

Method of assessment

Extended Writing: Essay (1,600 words) worth 40%
E-portfolio (2,000 words) worth 60%

All assessments must be passed to pass the module.
Reassessment: Like-for-like

Indicative reading

Learning outcomes

The intended subject specific learning outcomes. On successfully completing the module students will be able to:  

Explain the key principles and clinical applications of advanced therapies and ATMPs, including gene therapy, cell therapy, and tissue engineering.
Identify key tools, delivery methods, and vectors used in developing and producing advanced therapies.
Apply knowledge of upstream and downstream manufacturing processes, recognising the role of GMP and GCP in ensuring product quality and patient safety.
Analyse the regulatory, commercial, and logistical challenges involved in bringing advanced therapies to market, including cost, scalability, and reasons for failure.
Compile and present information on the development and clinical relevance of specific ATMP examples, demonstrating awareness of current industry practices and legislation.

Notes

  1. Credit level 5. Intermediate level module usually taken in Stage 2 of an undergraduate degree.
  2. ECTS credits are recognised throughout the EU and allow you to transfer credit easily from one university to another.
  3. The named convenor is the convenor for the current academic session.
Back to top

University of Kent makes every effort to ensure that module information is accurate for the relevant academic session and to provide educational services as described. However, courses, services and other matters may be subject to change. Please read our full disclaimer.